předchozí | následující

Jste zde:  Domů  > Datová knihovna  > Bibliografie  

Bibliografie

Abdulrahim, D. (2001), Substance misuse and mental health co-morbidity (dual diagnosis). Standards for mental health services, The Health Advisory Service, Londýn.

Andreasen, J. (2002), Ansvaret for de psykotivke stofmisbrugere skal vara psykiatriens. Ugeskrift for læger, 51.

AST/RELIS (2002), Point Focal OEDT Luxembourg – Direction de la Santé. Réseau National d’Information sur les Drogues et les Toxicomanies – RELIS – Rapport National, PFN, Lucemburk.

Bakken, K., Landheim, S. and Vaglum, P (2003), Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders? Alcohol and Alcoholism 38, 54–9.

Barrowclough, C., Haddock, G., Tarrier, N., et al. (2001), Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with co-morbidity schizophrenia. American Journal of Psychiatry 158, str. 1706–13.

Baudis, R. (2004), A drug court type project for juvenile drug-related offenders in Germany. Conference’s Acts: Substance Abuse, Drug Courts and Mental Health Treatment Services, Servizi Area Penale Carceri, Milán, 5.-7. února 2004

Beck, F. (2003), Dépistage de l’usage problématique de cannabis: échelle et référence (draft report), ESCAPAD, OFDT, Paříž.

Beck, F. and Legleye, S. (2003), Drogues et adolescence: usages de drogues et contextes d’usage entre 17 et 19 ans évolutions récentes ESCAPAD 2002, Paříž, OFDT.

Benschop, A., Rabes, M. a Korf, D. (2002), Pill testing – ecstasy and prevention. A scientific evaluation in three European cities , Rozenberg Publishers, Amsterodam.

Berglund, M. a kol., (ed.) (2003) Treating alcohol and drug abuse. An evidence-based review, Wiley, Londýn.

Berthel, T. (2003), Psychiatrische Komorbidität. V: Beubler, E., Haltmayer, H. a Springer, A. (eds) Opiatabhängigkeit. Interdisciplinäre Aspekte für die Praxis, Springer, Vídeň.

Best, D., Lan-Ho, M., Zador, D., a kol. (2000), Overdosing on opiates. Thematic review. Part I – causes. Drug and Alcohol Findings , č. 4, str. 4–20.

Best, D., Lan-Ho, M., Zador, D., a kol. (2001), Overdosing on opiates. Thematic review. Part II – prevention. Drug and Alcohol Findings, č. 5, str. 4–18.

Beutel, M. (1999), Sucht und sexueller Missbrauch. Psychotherapeut 44, str. 313–19.

Bird, S. a Rotily, M. (2002), Inside metdhodologies for counting blood-borne viruses and injector-inmates‘ behavioural risks – results from European prisons, Howard Journal 41 (2).

Bovenkerk, F. and Hogewind, W. I. M. (2002), Hennepteelt in Nederland: het probleem van criminaliteit en haar bestrijding. Utrecht, Willem Pompe Instituut voor Strafrechtswetenschappen.

Bronisch, T. a Wittchen, H.-U. (1998), Komorbidität von suizidalem Verhalten, Sucht, Depression und Angststörungen. Suizidprophylaxe 1, str. 22–6.

Chinman, M., Imm, P. a Wandersmann, A. (2004), Getting to outcomes 2004. Promoting accountability through methods and tools for planning, implementation, and evaluation, RAND Corporation, Santa Monica.

CND (2004), World drug situation with regard to drug trafficking: report to the Secretariat, Organizace spojených národů, Hospodářská a sociální rada, Vídeň.

Commonwealth Department for Health and Ageing [Ministerstvo Australského svazu pro zdravotnictví a stárnutí] (2003), National Co-morbidity Project. Current practice in the management of clients with co-morbidity mental disorders and substance use disorders in tertiary care settings, Australský svaz, Canberra.

Crawford, V. (2001), Co-existing problems of mental health and substance misuse (‘dual diagnosis’): a review of relevant literature, Royal College of Psychiatrists, Londýn.

Currie, C., Roberts, C., Morgan, A., et al. (2004), Young people's health in context. Health Behaviour in School-aged Children (HBSC) study: international report from the 2001/2002 survey, Health Policy for Children and Adolescents, č. 4, Ženeva, SZO Evropa.

Deehan, A. and Saville, E. (2003), Calculating the risk: recreational drug use among clubbers in the South East of England, on-line zpráva ministerstva vnitra 43/03.

Department of Health (2002a), Mental health policy implementation guide: dual diagnosis good practice guide, Ministerstvo zdravotnictví, Londýn.

Department of Health (2002b), Models of care for substance misuse treatment: promoting quality, efficiency and effectiveness in drug misuse treatment services. Full report for consultation, Ministerstvo zdravotnictví, Londýn.

Dialog (2000), Jahresbericht 1999. Verein Dialog – Hilfs- und Beratungsstelle für Suchtgiftgefährdete und deren Angehörige, Vídeň.

Dolan, K. (1997–98), Evidence about HIV transmission in prisons. Canadian HIV-AIDS Policy and Law Newsletter 3-4, str. 32–8.

Dolan, K., Rutter, S. and Wodak, A. D. (2003), Prison-based syringe exchange programmes: a review of international research and development. Addiction 98, str. 153–8.

Drake, R., Mercer-McFadden, C., Mueser, K., a kol. (1998), Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin 24, str. 589–608.

DrugScope (2004), Druglink 19 (1) leden/únor 2004.

Dusenbury, L. a Falco, M. (1995), Eleven components of effective drug abuse prevention curricula ]. Journal of School Health 65, str. 420–5.

Eland, A. a Van de Glint, G. (2001), Diagnostiek en behandeling van ADHD binnen de intramurale verslavingszorg, Trimbos Instituut, Utrecht.

EMCDDA (2001), Cocaine and crack (special issue). V Annual report 2001: the state of the drugs problem in the acceding and candidate countries to the European Union, Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2003a), Annual report 2003: the state of the drugs problem in the acceding and candidate countries to the European Union, Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2003b), Annual report 2003: the state of the drugs problem in the European Union and Norway, Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2003c), Drugs in focus no. 11: Hepatitis C: a hidden epidemic, Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2003d), The international profile of cannabis clients, expert meeting on treatment demand – meeting with International organisations, Lisabon, 24. června 2003.

EMCDDA (2004a) European report on drug consumption rooms, Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2004b), Drugs in focus no. 13: Deaths. Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2004c), An overview of cannabis potency in Europe, EMCDDA Insights 6. Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

EMCDDA (2004d), Hepatitis C and injecting drug use: impact, costs and policy options. EMCDDA Monographs 7. Evropské monitorovací centrum pro drogy a drogovou závislost, Lisabon.

Emmanuelli, J. (2003), Siamois: Tendances en matière de réduction des risques chez les usagers de drogues par voie iv. V: Bello, J.-Y., Toufik, A., Gandilhon, M., a kol. (eds) Phénomènes émergents liés aux drogues en 2002, quatrième rapport national du dispositif TREND, str. 263–7. OFDT, Paříž.

Estebanez, P., Russell, N. K., Aguilar, M.D., a kol. (2001), Determinants of HIV prevalence amongst female IDU in Madrid. European Journal of Epidemiology 17, str. 573–80.

European Centre for the Epidemiological Monitoring of AIDS (EuroHIV) (2004), HIV/AIDS Surveillance in Europe, End-year report, 2003, č. 70. Saint-Maurice, Institut de Veille Sanitaire.

Evropská komise (1999), Evaluating socio-economic programmes: glossary of 300 concepts and technical terms, Lucemburk, Úřad pro úřední tisky Evropských společenství.

Evropská komise (2003), Evaluating EU activities – a practical guide for Commission Services, Lucemburk, Úřad pro úřední tisky Evropských společenství.

Europol (2002), Serious crime overviews: counter money laundering, a European Union perspective, Europol, Haag.

Europol (2003), European Union organised crime report, Europol, Haag.

Facy, F. (1999), Toxicomanes et prescription de méthadone, EDK, Paříž.

Farrell, M. (2002), Final Evaluation of the Pilot Drug Court, Courts Service, Dublin.

FATF (2003a), Annual report 2002–2003.

FATF (2003b), Combating the abuse of alternative remittance systems: international best practices, FATF, Paříž.

Flay, B. (2000), Approaches to substance use prevention utilizing school curriculum plus social environment change. Addictive Behaviours 25, str. 861–6.

Fridell, M. (1991), Personlighet och drogmissbruk. En forskningsöversikt. PM-serie 10, Centralförbundet för alkohol- och narkotikaupplysnings (CAN), Stockholm.

Fridell, M. (1996), Psykisk störning och narkotikamissbruk. Socialstyrelsen. Psykiskt störda missbrukare. SoS-rapport 1996: 14, Socialstyrelsen, Stockholm.

Gerdner, A. (2004), Utfall av LVM-vård: översikt och syntes av hittilsvarande studier. Bilaga 4 till LVM-utredningen, SOU 2004: 3 Tvång och förändring – Rättssäkerhet, vårdens innehåll och eftervård, Socialdepartementet, Stockholm.

GFATM Secretariat (2004), The Global Fund Grant status report.

Giuliani, M. a Suligoi, B (2004), Italian STI Surveillance Working Group. Differences between nonnational and indigenous patients with sexually transmitted infections in Italy and insight into the control of sexually transmitted infections. Sexually Transmitted Diseases 31(2), str. 79–84.

Gore, S.M. (1999), Fatal uncertainty: death-rate from use of ecstasy or heroin. Lancet 354, str. 1265–6.

Hall, W., Degenhardt,L. a Lynskey, M (2001), The health and psychological effects of cannabis use, Monograph Series no. 44, 2. vydání, Australský svaz: Canberra.

Hannon F., Keleher C., and Friel, S. (2000). General healthcare study of the Irish prison population, Stationery Office, Dublin.

Hansen, W. (1992), School-based substance abuse prevention: a review of the state of the art in curriculum, 1980–1990. Health Education Research 7, str. 403–30.

Hibell, B., Andersson, B., Ahlstrom, S., a kol., (2000), The 1999 ESPAD Report: The European School Survey Project on Alcohol and Other Drugs . Švédská rada pro informace o alkoholu a dalších drogách (CAN) a Rada Evropy, Skupina Pompidou.

Hope, V., Ncube, F., de Souza, L., a kol. (2004), Shooting up: infections in injecting drug users in the United Kingdom, 2002 Eurosurveillance Weekly 8(4): 22. ledna 2004.

INCB (2004a), Report of the International Narcotics Control Board 2003, Organizace spojených národů. INCB: New York.

INCB (2004b), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, Organizace spojených národů, INCB: New York.

Interpol (2002), Activities report, Interpol: Lyon.

Jansson, I. and Fridell, M. (2003), Psykisk och somatisk belastning hos tvångsvårdade kvinnor, LVM och LVU-vårdade kvinnor vid Lunden, SiS-rapport 1/03. Statens Institutionsstyrelse, Stockholm.

Joint Meeting of the Faculty of Substance Misuse of the Royal College of Psychiatrists and the World Psychiatric Association 2003, Innovations in the treatment of addiction , Barcelona, 1.–2. května 2003.

Jonsson, S. (2001) Långstorps vård- och behandllingshem – En ufallsstudie. Psykologexamensuppsats Vol. III:20,Institutionen för psykologi: Lund.

Kessler, R.C., Aguilar-Gaxiola S., Andrade L., a kol. (2001), Mental-substance comorbidities in the ICPE surveys. Psychiatrica Fennica 32, str. 62–79.

Kokkevi, A. a Facy, F. (1995), Personality traits and psychopathology in drug addiction. European Addiction Research 1, str. 194–8.

Kokkevi, A. and Stefanis, C. (1995), Drug abuse and psychiatric comorbidity. Comprehensive Psychiatry 36, str. 329–37.

Kraus, L., Augustin, R., Korf, D., a kol. (2003), Cannabis use in France, Germany, Greece and Spain: has age of first use experience shifted towards younger age? (zpráva).

Krausz, M. (1996), Old problems – new perspectives European Addiction Research 2, str. 1–2.

Krausz, M. (1999), úvodník. Editorial. Addiction and mental health. European Addiction Research 5, str. 53–4.

Krausz, M. (1999), Komorbidität – Psychische Störungen bei Schwerstabhängigen; Forschungsstand und klinische Konsequenzen. V: Bellebaum, C. Jellinek, C. a Westermann, B. (eds) Mehr als Abhängig? Versuche mit Methadon und Heroin, str. 100–14. Deutscher Studienverlag, Weinheim.

Krausz, M., Verthein, U. a Degkwitz, P. (1999), Psychiatric co-morbidity in opiate addicts. European Addiction Research 5, str. 55–62.

Landheim, A. S., Bakken, K. and Vaglum, P. (2003), Gender differences in the prevalence of substance disorders and personality disorders among poly-substance abusers and pure alcoholics, European Addiction Research 9, str. 8–17.

Lauritzen, G, Waal, H, Amundsen, A. a Arner, O. (1997), A nationwide study of Norwegian drug abusers in treatment: methods and findings. Nordisk alkohol- & narkotikatidsskrift 14, str. 43–63.

Ley, A., Jeffery, D.P., McLaren, S. a Siegfried, N. (2003), Psychosocial treatment programmes for people with both severe mental illness and substance misuse . Cochrane Review. The Cochrane Library, č. 4, Wiley, Chichester, Velká Británie.

Liappas, J. (2001), Drug addiction: a multidimensional therapeutic problem. Itaca 6, str. 9–22.

Lima, A. R., Lima, M. S., Soares, B. G. O. a Farrell, M. (2004a), Carbamazepine for cocaine dependence. Cochrane Review. The Cochrane Library, č. 2, 2004.

Lima, M. S., Reisser, A. A. P., Soares, B. G. O., Farrell, M. (2004b), Antidepressants for cocaine dependence. Cochrane Review. The Cochrane Library, č. 2, 2004.

Long, J., Allwright, S. and Begley, C. (2004) , Prisoners’ views of injecting drug use and harm reduction in Irish prisons. International Journal of Drug Policy, v tisku.

Marsden, J., Gossop, M., Stewart, D., a kol. (2000), Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment outcome study. British Journal of Psychiatry 176, str. 285–9.

McIntosh, C. and Ritson, B (2001), Treating depression complicated by substance misuse. Advances in Psychiatric Treatment 7, str. 357–64.

McVeigh, J., Beynon, C. a Bellis, M. A. (2003), New challenges for agency based exchange schemes: analysis of 11 years of data (1991–2001) in Merseyside and Cheshire, United Kingdom. International Journal of Drug Policy 14, str. 399–405.

Mears, A., Clancy, C., Banerjee, S., et al. (2001), Co-existing problems of mental disorder and substance misuse (dual diagnosis): a training needs analysis, Royal College of Psychiatrists, Londýn.

Migliori, G.B. a Centis, R. (2002), Problems to control TB in eastern Europe and consequences in low incidence countries. Monaldi Archive of Chest Diseases 57, str. 285–90.

Morel, A. (1999), Troubles psychiatriques associés à la toxicomanie. Interventions 72, str. 35–40.

Moyle, P. (2003), International drug court developments, models and effectiveness, Pompidou Group Drug Court Project, Štrasburk.

Murphy-Lawless, J. (2002), Fighting back: women and the impact of drug abuse on families and communities, Liffey Press, Dublin.

Murray, R., Grech, A., Phillips, P. a Johnson, S. (2003), What is the relationship between substance abuse and schizophrenia? V: Murray, R., Jones, P., Susser, E., a kol. (red.), The epidemiology of schizophrenia , Cambridge University Press, Cambridge.

Neale, J. a Robertson, M. (2004), Recent cocaine and crack use among new drug treatment clients in Scotland. Drugs: Education, Prevention and Policy 11(1), str. 79–90.

Nestler, E. J. (2001), Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience 2(2):119–28.

Öjehagen, A. and Schaar, I. (2003) Mentally ill substance abusers in Sweden: a 5-year follow-up of a multisite study of co-operation between psychiatric services and social authorities V: Carrà, G. a Clerici, M. (eds) Dual diagnosis: filling the gap, John Libbey Eurotext, Paříž.

Olin, N. a Plasait, B. (2003), Drogue: l’autre cancer. Rapport de la Commission d’enquête sur la politique nationale de lutte contre les drogues illicites. Sénat, Paříž.

Origer, A. a Delucci, H. (2002), Etude épidemiologique et méthodologique des cas de décès liés à l’usage illicite des substances psycho-actives. Analyse comparative (1999–2000), Séries de recherche no. 3, Kontaktní místo EMCDDA Luxembourg-CPR Santé, Lucemburk.

Paglia, A. a Room, R. (1999), Preventing substance use problems among youth: a literature review and recommendations. Journal of Primary Prevention 20(1), str. 3–50.

Pani, P. P., Trogu, E., Carboni, G., a kol. (2003), Psychiatric severity and treatment response in methadone maintenance treatment programmes: new evidence. Heroin Addiction & Related Clinical Problems 5, str. 23–36.

Pedersen, M. U. (2001), Substitutionsbehandling. Organiseringer, stofmisbrugere, effekter, metoder. Del 1. Center for Rusmiddelforskning, Aarhus Universitet, Århus.

Popov, P. (2003), Alkohol. V: Kalina, K. a spol. (ed.) Drogy a drogové závislosti – mezioborový přístup, Kapitola 3/1, Praha, Úřad vlády ČR – NMC.

Ravelli, A., Bijl, R. V. a Van Zessen, G. (1998), Comorbiditeit van psychiatrische stoornissen in de Nederlandse bevolking; resultaten van de Netherlands Mental Health Survey and Incidence Study (NEMESIS). Tijdschrift voor Psychiatrie 40, str. 531–44.

Národní zprávy zemí zapojených do sítě Reitox.

Rhodes, T., Lilly, R., Fernández, C., a kol. (2003), Risk factors associated with drug use: the importance of ‘risk environment’ Drugs: Education, Prevention and Policy 10, str. 303–29.

Roeg, D. P. K., van de Goor, L. A. M. a Garretsen, H. F. L. (2004) When a push is not a shove: assertive care, Dutch-style. Drugs and Alcohol Today, Vol 4 (v tisku).

Rooney, S., Kelly, G., Bamford, L., a kol. (1999), Co-abuse of opiates and benzodiazepines . Irish Journal of Medical Science 168: 36–41.

SAMHSA, Office of Applied Studies (2001), Trends in initiation of substance use, 2001 National Household Survey on Drug Abuse (NHSDA) .

SAMHSA, Office of Applied Studies (2002), Results from the 2002 National Survey on Drug Use and Health. National findings.

Schifano, F., Oyefeso, A., Corkery, J., a kol. (2003), Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002 . Human Psychopharmacology and Clinical Exposure 18, str. 519–24.

Seivewright, N., Donmall, D., Douglas, J., a kol. (2000), Cocaine misuse treatment in England. International Journal of Drug Policy 11, str. 203–15.

Siliquini, R., Zeppegno, P. and Faggiano, F. (2002), Patologia psichiatrica e consumo di sostanze: descrizione preliminare dei casi di uno studio caso–controllo. V: Faggiano, F. (ed.) OED Piemonte – Rapporto 2002, Turin, Osservatorio Epidemiologico Dipendenze.

Sosial- og helsedepartementet (1999), Rapportane I, II, III, frå Arbeidsgruppa for å gjennomgå hjelpe- og behandlingstilbodet for rusmiddelmisbrukarar.

Springer, A. (2003a) Different types of medically assisted treatment. Treatment monitoring conference, EMCDDA, Lisabon.

Springer, A. (2003b), Psychotherapeutische Aspekte. V: Beubler, E., Haltmayer, H. and Springer, A. (eds) Opiatabhängigkeit. Interdisziplinäre Aspekte für die Praxis, Springer, Vídeň.

Stothard, B., a Ashton, M. (2000), Education’s uncertain saviour. Drug and Alcohol Findings 3, str. 4–7, 16–20.

Stöver, H. (2001), Bestandsaufnahme ‘Crack Konsum’ in Deutschland: Verbreitung, Konsummuster, Risiken und Hilfeangebote. Endbericht. Brémy, Univerzita Brémy, Institut pro výzkum drog (BISDRO).

Stöver, H. a Nelles, J. (2003), Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy 14, str. 437–44.

Ter Bogt, T. a Engels, R. C. M. E. (2004). Party style: notice for and effects of MDMA at Rave parties. Substance Use and Misuse.

Tobler, N. (2001), Prevention is a two-way process. Drug and Alcohol Findings, č. 5, str. 25–7.

Tobler, N. a Stratton H.H. (1997), Effectiveness of school-based drug prevention programs: a meta-analysis of the research . Journal of Primary Prevention 18(1), str. 71–128.

Tobler, N. S., Roona, M. R. a Ochshorn, P. (2000), School-based adolescent prevention programs: 1998 meta-analysis. Journal of Primary Prevention 20, str. 275–336.

Uchtenhagen, U. a Zeiglgänsberger, W (2000), Suchtmedizin – Konzepte, Strategien und therapeutisches Management, Urban & Fischer Verlag, Mnichov.

UNODC [ (2003a), Global illicit drug trends 2003, Úřad OSN pro kontrolu drog a prevenci kriminality, Vídeň.

UNODC (2003b), Ecstasy and amphetamines: global survey 2003, Úřad OSN pro kontrolu drog a prevenci kriminality, Vídeň.

UNODC a vláda Maroka (2003), Morocco cannabis survey 2003, Úřad OSN pro kontrolu drog a prevenci kriminality, Vídeň.

UNODCCP (Úřad OSN pro kontrolu drog a prevenci kriminality) (2000), Demand reduction: a glossary of terms, OSN, New York.

Vaglum, P. (1996) Psychopathology and substance abuse: clinical Lessons from six Norwegian Studies Psychiatric Fennica 27: 55–67.

Van den Bosch, L. M., Verheul, R. a Van den Brink, W. (2001), Substance abuse in borderline personality disorder: clinical and etiological correlates. Journal of Personality Disorders 15, str. 416–24.

Van Rooijen, M. (2001), Zendingswerk: dubbele diagnose kliniek. Psy 5, str. 24–8.

Verheul, R. (2001), Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry 16, str. 274–82.

WCO (2003a), Drug routes from Central Asia to Europe (viz internetovou stránku WCO).

WCO (2003b), An integrated international response to drug smuggling . WCO, Brusel.

WCO (2003c), World money laundering report, díl 4, č. 10.

Weaver, T., Madden, P., Charles, V., a kol. (2003), Co-morbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry 183, str. 304–12.

WHO (1995), Lexicon of alcohol and drug terms, SZO, Ženeva.

Wiessing, L. a Kretzschmar, M. (2003), Can HIV epidemics among IDUs ‘trigger’ a generalised epidemic? International Journal of Drugs Policy 14, str. 99–102.

Williams, H., O’Connor, J. J. a Kinsella, A. (1990), Depressive symptoms in opiate addicts on methadone maintenance . Irish Journal of Psychological Medicine 7, str. 45–6.

Wolf, J., Mensink, C., a Van der Lubbe, P. (2002), Casemanagement voor langdurig verslaafden met meervoudige problemen: een systematisch overzicht van interventie en effect, Ontwikkelcentrum Sociaal Verslavingsbeleid, Utrecht.

Zuckerman, J. (2003), The place of accelerated schedules for hepatitis A and hepatitis B vaccinations . Drugs 63, str. 1779–84.

Zurhold, H., Kreutzfeldt, N., Degkwitz, P. a Verthein, U. (2001), Drogenkonsumräume. Gesundheitsförderung und Minderung öffentlicher Belastungen in europäischen Grossstädten. Lambertus, Freiburg.